| BCBS Federal Medical & Drug | 2.04.150 Serologic Genetic and Molecular Screening for Colorectal Cancer | 2026-03-01 |
| BCBS Federal Medical & Drug | 2.04.151 Germline and Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Breast Cancer (BRCA1, BRCA2, PIK3CA, Ki-67, RET, BRAF, ESR1, NTRK) | 2026-03-01 |
| BCBS Federal Medical & Drug | 6.01.26 Oncologic Applications of Positron Emission Tomography Scanning (Genitourinary) | 2026-03-01 |
| BCBS Federal Medical & Drug | 6.01.33 Wireless Capsule Endoscopy for Gastrointestinal Disorders | 2026-03-01 |
| BCBS Federal Medical & Drug | 6.01.49 Computed Tomography Perfusion Imaging of the Brain | 2026-03-01 |
| BCBS Federal Medical & Drug | 6.01.51 Interim Positron Emission Tomography Scanning in Oncology to Detect Early Response During Treatment | 2026-03-01 |
| BCBS Federal Medical & Drug | 6.01.61 Oncologic Applications of Positron Emission Tomography Scanning (Gastrointestinal and Pancreatic) | 2026-03-01 |
| BCBS Federal Medical & Drug | 6.01.62 Oncologic Applications of Positron Emission Tomography Scanning (Breast and Gynecologic) | 2026-03-01 |
| BCBS Federal Medical & Drug | 6.01.63 Oncologic Applications of Positron Emission Tomography Scanning (Bone and Sarcoma) | 2026-03-01 |
| BCBS Federal Medical & Drug | 6.01.64 Oncologic Applications of Positron Emission Tomography Scanning (Hematologic) | 2026-03-01 |